About Applied Immune Technologies
Applied Immune Technologies is a company based in Haifa (Israel) founded in 2006 was acquired by Adicet Bio in January 2016.. Applied Immune Technologies has raised $4 million across 2 funding rounds from investors including Adicet Bio and Pontifax Venture Capital. Applied Immune Technologies operates in a competitive market with competitors including Jazz Pharmaceuticals, C4 Therapeutics, Erasca, Revolution Medicines and MiRagen, among others.
- Headquarter Haifa, Israel
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$4 M (USD)
in 2 rounds
-
Latest Funding Round
$600 K (USD), Grant
Jan 01, 2011
-
Investors
Adicet Bio
& 1 more
-
Employee Count
Employee Count
-
Acquired by
Adicet Bio
(Jan 27, 2016)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Applied Immune Technologies
Applied Immune Technologies has successfully raised a total of $4M across 2 strategic funding rounds. The most recent funding activity was a Grant round of $600 thousand completed in January 2011. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Grant — $600,000
-
First Round
First Round
(26 Apr 2010)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan, 2011 | Amount | Grant - Applied Immune Technologies | Valuation |
investors |
|
| Apr, 2010 | Amount | Series A - Applied Immune Technologies | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Applied Immune Technologies
Applied Immune Technologies has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Adicet Bio and Pontifax Venture Capital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Pontifax Venture Capital is focused on life sciences investments.
|
Founded Year | Domain | Location | |
|
Immune cell therapies for cancer treatment are developed.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Applied Immune Technologies
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Applied Immune Technologies
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Applied Immune Technologies Comparisons
Competitors of Applied Immune Technologies
Applied Immune Technologies operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Jazz Pharmaceuticals, C4 Therapeutics, Erasca, Revolution Medicines and MiRagen, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Novel biopharmaceutical medicines are developed for unmet medical needs.
|
|
| domain | founded_year | HQ Location |
Small-molecule drugs for cancer treatment are developed via Degronimid platform.
|
|
| domain | founded_year | HQ Location |
Small molecule therapeutics for cancer treatment are developed.
|
|
| domain | founded_year | HQ Location |
Cancer therapies are developed using selective pathway inhibitors.
|
|
| domain | founded_year | HQ Location |
MicroRNA-based therapeutics are developed for treating multiple diseases.
|
|
| domain | founded_year | HQ Location |
Therapeutics for cancer and rare diseases are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Applied Immune Technologies
When was Applied Immune Technologies founded?
Applied Immune Technologies was founded in 2006 and raised its 1st funding round 4 years after it was founded.
Where is Applied Immune Technologies located?
Applied Immune Technologies is headquartered in Haifa, Israel. It is registered at Haifa, Haifa District, Israel.
Is Applied Immune Technologies a funded company?
Applied Immune Technologies is a funded company, having raised a total of $4M across 2 funding rounds to date. The company's 1st funding round was a Series A of $4M, raised on Apr 26, 2010.
What does Applied Immune Technologies do?
Applied Immune Technologies was founded in 2006 in Haifa, Israel, within the biotechnology sector. Therapeutic molecules are developed for cancer, viral, and autoimmune diseases. T-Cell Receptor-Like (TCRL) antibodies, targeted at intracellular-derived peptides, are created for therapeutic and diagnostic uses. These include pathology diagnostics, vaccine design, validation, monitoring, and antigen presentation analysis in disease states. Technology for discovering TCRL targets is also applied.
Who are the top competitors of Applied Immune Technologies?
Applied Immune Technologies's top competitors include Jazz Pharmaceuticals, C4 Therapeutics and Erasca.
Who are Applied Immune Technologies's investors?
Applied Immune Technologies has 2 investors. Key investors include Adicet Bio, and Pontifax Venture Capital.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.